These findings are consistent with our previously reported observations with cells expressing the Δ716-G-CSFR [10], and suggest that defective ubiquitination contributes to the aberrant cellular response of cells from patients with SCN/AML to G-CSF. The gene discussed is CSF3; the disease is acute myeloid leukemia.